Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript
Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript
Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.14 per share a year ago.
Countdown to Elanco Animal Health (ELAN) Q4 Earnings: Wall Street Forecasts for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Elanco Animal Health (ELAN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Elanco Animal Health: Innovation-Led Growth Model Plus Credible Deleveraging Path
Elanco Animal Health earns a buy rating, driven by robust product innovation, commercial execution, and a credible deleveraging plan. ELAN's 'Big 6' innovation portfolio is set to contribute ~$1.1 billion in 2026 revenue, supporting margin expansion and portfolio renewal. Credelio Quattro and Zenrelia demonstrate ELAN's ability to capture share from incumbents, with rapid adoption and strong sequential growth.
Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year?
Here is how Elanco Animal Health Incorporated (ELAN) and Tactile Systems Technology (TCMD) have performed compared to their sector so far this year.
All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy
Elanco Animal Health (ELAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript
Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Q3 2025 Earnings Call Transcript
Elanco Animal Health Incorporated ( ELAN ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Tiffany Kanaga Jeffrey Simmons - President, CEO & Director Robert VanHimbergen - Executive VP & CFO Conference Call Participants Umer Raffat - Evercore ISI Institutional Equities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Andrea Zayco Narvaez Alfonso - UBS Investment Bank, Research Division Michael Ryskin - BofA Securities, Research Division Linda Bolduc - Morgan Stanley, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Navann Ty Dietschi - BNP Paribas, Research Division Andrew Dusing - Cleveland Research Company LLC Presentation Operator Ladies and gentlemen, thank you for standing by.
Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics
The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
